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Chitin synthesis and fungal pathogenesis
Megan D Lenardon, Carol A Munro and Neil AR GowChitin is an essential part of the carbohydrate skeleton of the
fungal cell wall and is a molecule that is not represented in
humansandother vertebrates.Complex regulatorymechanisms
enable chitin to bepositioned at specific sites throughout the cell
cycle tomaintain theoverall strengthof thewall andenable rapid,
life-saving modifications to be made under cell wall stress
conditions. Chitin has also recently emerged as a significant
player in the activation and attenuation of immune responses to
fungi and other chitin-containing parasites. This review
summarises latest advances in the analysis of chitin synthesis
regulation in the context of fungal pathogenesis.
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Introduction
Chitin is an essential component of the cell walls and
septa of all pathogenic fungi, and occurs in the cyst walls
of pathogenic amoebae, the egg-shells and gut lining of
parasitic nematodes and the exoskeletons of invertebrate
vectors of human disease including mosquitoes, sand
flies, ticks and snails. Despite the fact that chitin is only
outweighed in abundance in nature by cellulose and is
present and essential in so many parasites and pathogens,
fundamental information about its biosynthesis and
recognition by the immune system is lacking.
Chitin, a b(1,4)-linked homopolymer of N-acetylglucosa-
mine, is a simple polysaccharide that is represented in the
cell walls of all fungi studied to date [1,2]. The nascent
primary polysaccharide of fungi folds back on itself to
form anti-parallel chains, which form intra-chain hydro-
gen bonds that further stiffen the carbohydrate into
immensely strong fibrous microfibrils tougher than any
other molecule in nature, and stronger, weight-for-
weight, than bone or steel (Figure 1). The 3D network
of chitin microfibrils is covalently attached to b(1,3)-
Open access under CC BY license.Current Opinion in Microbiology 2010, 13:416–423glucan — a second load-bearing polysaccharide present
in most fungal cell walls [3]. In many species, such as the
human pathogen Candida albicans, the major classes of
cell wall proteins are attached through a GPI-remnant to
b(1,3)-glucan or chitin via a branched b(1,6)-glucan linker
[3]. A variable proportion of fungal chitin is synthesised
and then deacetylated to chitosan by the action of one or
more chitin deacetylases. In C. albicans, less than 5% of
chitin is deacetylated to chitosan, while most zygomy-
cetes and the basidomycete Cryptococcus neoformans have
more than two thirds deacetylated to chitosan [4,5].
Chitin deacetylation may make the polymer more elastic
and protect it from the action of hostile chitinases.
The apparent simplicity of the chitin primary structure
belies a complex underlying biosynthetic process. Chitin is
synthesised by large families of chitin synthase (CHS)
enzymes that fall into seven discernable classes
(Table 1). We have chosen to follow the classification
proposed by Nin˜o-Vega et al. [6] and Roncero [7], and
not that of Chigira et al. [8] and Choquer et al. [9] who
reverse classes VI and VII. The functional significance of
all CHS classes is not clear and seems to differ in different
fungi [1,2]. The roles of individual CHS genes have been
investigated principally by analysis of specific CHS
deletion strains.Class I enzymes aremost readilymeasured
in in vitro biochemical assays, yet they normallymake only
a minor fraction of cell wall chitin, and mutants lacking
class I CHS genes are invariably viable with mild pheno-
types under non-stressed conditions [1]. Class II enzymes
often are immeasurable in enzyme assays, and make little
chitin, but their deletion results in marked deleterious
effects on cell viability through effects on vital processes
such as primary septum formation [10]. Class IV enzymes
oftenmake substantial amounts of wall chitin, butmutants
are usually viable although sometimes attenuated in viru-
lence [11]. Class IV, V and VII sequences share some
sequence homology, and class V and some class VII
proteins also contain myosin-like domains. Class III, V,
VI and VII have only been identified in filamentous fungi
and some dimorphic fungi and are absent from yeasts like
Saccharomyces cerevisiae and C. albicans.
The multiplicity of CHS enzymes suggests that they may
have redundant roles in cell wall synthesis. This is the
case for some but not all CHS enzymes. It is clear that the
expression and activity of CHS is highly regulated both
throughout the cell cycle and under conditions of stress,
such as in response to potentially lethal challenges to cell
integrity imposed by lytic enzymes or antibiotics or
oxidants that are generated by the respiratory burst within
the phagolysomes of lymphocytes.www.sciencedirect.com
Chitin synthesis and fungal pathogenesis Lenardon, Munro and Gow 417
Figure 1
Chitin structure and diversity in fungi. Chitin is a b(1,4)-homopolymer of N-acetylglucosamine that folds in an anti-parallel manner forming intra-chain
hydrogen bonds. Chitin chains are cross-linked covalently to b(1,3)-glucan (green) to form the inner skeleton of most fungi. Examples of shadow cast
electron microscopy images of chitin from (a) Neurospora crassa; (b) Coprinus cinereus; (c) chitin–chitosan from Mucor mucedo; and (d) Candida
albicans. In (e) and (f), the structure of chitin from C. albicans is shown in a chs3D and chs8D mutant, respectively, demonstrating that the architecture
of chitin is genetically determined [24].Transcriptional regulation of chitin synthesis
In most fungi, chitin and cell wall synthesis occurs at sites
of polarised growth. During early bud growth, cell wall
material is deposited at the bud tip [12]. A period ofwww.sciencedirect.comisotropic growth occurs in large budded cells where
material is deposited over the entire bud surface. Follow-
ing nuclear division, a repolarisation phase begins where
material is directed towards the mother-bud neck toCurrent Opinion in Microbiology 2010, 13:416–423
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Table 1
Members of the seven classes of CHS enzymes in various fungia
Fungusb I II III IV V VI VII Total
S. cerevisiaed Chs1 Chs2 Chs3 3
C. albicansd Chs2
Chs8
Chs1 Chs3 4
A. nidulansd ChsC ChsA ChsB
ChsF
ChsD CsmA ChsG CsmB 8
A. fumigatusd ChsA ChsB ChsC
ChsG
ChsF ChsE ChsD Afu2g13430 8
W. dermatitidisd Chs2 Chs1 Chs3 Chs4 Chs5 Chs6 Chs7 7
U. maydise Chs3
Chs4
Chs2 Chs1 Chs5
Chs7
Mcs1 Chs6 8
C. neoformanse Chs6
Chs8
Chs6
Chs8
Chs2
Chs7
Chs1
Chs3
Chs5 Chs4 8
P. blakesleeanusf Chs5
Chs6
Chs1
Chs2
Chs3
Chs4
Chs7
Chs8
Chs9
Chs10
10c
a Standard genetic nomenclature for S. cerevisiae and C. albicans has been used to designate CHS proteins from all fungi. The enzymes have been
assigned to classes based on the classification proposed by Nin˜o-Vega et al. [6] and Roncero [7].
b d: ascomycete; e: basidomycete; and f: zygomycete.
c 34 putative CHSs have been annotated in the P. blakesleeanus genome (http://genome.jgi-psf.org/Phybl2/Phybl2.home.html).prepare for cytokinesis. In hyphal or filamentous forms,
cell extension is a continuous and indefinite process of
apical growth [13].
Accordingly, chitin synthesis must be regulated both
temporally and spatially in relation to the cell cycle.
The S. cerevisiae class II enzyme ScChs2 synthesises
the primary septum and ScChs1 of class I acts a repair
enzyme that replenishes chitin in the birth/bud scar
immediately after cytokinesis [1,14]. A genome-wide
analysis of cell cycle regulation at the mRNA level using
synchronised S. cerevisiae cultures indicated that expres-
sion of ScCHS2 peaked in M-phase and ScCHS1 in M/G1,
both at appropriate times for the functions of these
enzymes [15]. Transcription during the cell cycle of an
opaque C. albicans MTLa FAR1OP strain synchronised
after release from a-factor arrest showed that expression
of CaCHS1 (orthologous to ScCHS2), CaCHS8 and to a
lesser extent CaCHS3 peaked in G2 phase, whereas
expression of CaCHS2 was non-periodic [16].
Disruption of cell wall biosynthetic genes or treatments
with cell wall perturbing agents often results in compen-
satory alterations in the cell wall, including activation of
chitin synthesis, in an attempt to maintain cellular integ-
rity (reviewed in [17]). Defects in the cell wall are sensed
in S. cerevisiae by transmembrane proteins such as ScWsc1
and ScMid2, or the signalling mucins ScMsb2 and ScHkr1
that activate downstream mitogen-activated protein
(MAP) kinase cascades to bring about cell wall remodel-
ling (Figure 2). In S. cerevisiae this so-called ‘cell wall
salvage’ or ‘cell wall compensatory’ pathway is mediated
primarily through the protein kinase C (PKC) cell integ-
rity MAP kinase cascade and its downstream target theCurrent Opinion in Microbiology 2010, 13:416–423transcription factor ScRlm1 [18]. A second MAP kinase
cascade, the high osmolarity glycerol response (HOG)
pathway, has also been suggested to play a role in reg-
ulating cell wall architecture [19] (Figure 2).
In C. albicans, the PKC and HOG MAP kinase cascades
and the Ca2+/calcineurin pathway regulate CHS gene
expression and chitin synthesis in response to cell wall
stresses [20]. Promoter dissection experiments have
defined the regulatory regions of the class I CHS pro-
moter sequences and revealed that C. albicans uses differ-
ent transcription factors and/or consensus binding
sequences to regulate chitin synthesis compared to S.
cerevisiae [21] (Figure 2).
Upregulation of chitin synthesis in response to cell wall
stress may be clinically relevant. In C. albicans, the tran-
scriptional activation of chitin synthesis through the PKC,
HOG and Ca2+/calcineurin pathways confers resistance to
the echinocandin class of antifungal drugs [22], and in
Aspergillus fumigatus, calcineurin-mediated elevated tran-
scription of AfCHSA and AfCHSC is required for paradox-
ical growth in the presence of high concentrations of the
echinocandin drug caspofungin [23].
Post-transcriptional regulation of chitin
synthesis
Coordinated synthesis of chitin also requires the localis-
ation of the enzymes to be regulated throughout the cell
cycle. Fungal CHS enzymes that are responsible for
synthesising cell wall and/or septal chitin tend to be
localised to sites of polarised growth. For example, in
C. albicans, the class IV enzyme CaChs3 is involved in
both cell wall and septum synthesis [11]. It is localised towww.sciencedirect.com
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Figure 2
Signalling pathways that regulate Candida albicans CHS gene expression. The HOG, PKC and the Ca2+/calcineurin signalling pathways regulate
chitin synthesis and CHS gene expression [20]. The Rlm1 transcription factor downstream of the PKC MAP kinase cascade controls the expression
of a number of cell wall related genes in S. cerevisiae. Putative Rlm1 binding motifs (red boxes) in the promoters of CaCHS2 and CaCHS8 contribute
to their cell wall stress-activated regulation [21]. Activation of the calcineurin pathway results in de-phosphorylation of the CaCrz1 transcription
factor. CaCrz1 then moves to the nucleus and induces expression of genes with CDREs (calcium-dependent response elements) within their
promoter sequences. C. albicans has significant re-wiring of signalling pathways compared to S. cerevisiae, for example, the role of the CaSko1
transcription factor in response to caspofungin is independent of the CaHog1 MAP kinase but involves the CaPsk1 PAS kinase [26]. Potential CDREs
and Sko1 binding sites identified in silico upstream of CaCHS2 and CaCHS8 (grey boxes) were not required for regulation of gene expression [21].
Sequences in the first 347 bp and 125 bp of the CaCHS2 and CaCHS8 promoters governed expression through these three signalling pathways
[21].Adapted from [17].the tip of growing buds and hyphae and relocates to sites
of septum formation before cytokinesis [24]. Similarly, in
A. nidulans, the class III enzyme AnChsB appears to
function at polarised growth sites and in forming septa
during hyphal growth and conidia development [25].
Both the localisation and stability of CHS enzymes can be
regulated by phosphorylation. Recent work has shown
that protein kinases and the establishment of cell polarity
appear to be important for cell wall regulation in C.
albicans [26]. In S. cerevisiae, the primary septum is syn-
thesised by ScChs2 [1,14]. Phosphorylation of ScChs2 by
ScCdk1 at 4 N-terminal sites retains this enzyme in the
Endoplasmic Reticulum (ER) until mitotic exit [27].
Deletion of these phospho-sites resulted in ScChs2 degra-
dation [28], indicating that phosphorylation regulates
chitin synthesis by ScChs2 at specific stages of the cellwww.sciencedirect.comcycle, either by regulating the cellular localisation or
stability of the protein. Three of the four CHS enzymes
are phosphorylated in C. albicans [29], and phosphoryl-
ation of CaChs3 on S139 is required to target this enzyme
to sites of polarised growth [30] (Figure 3).
The regulation of localisation of the class IV CHS enzyme
in S. cerevisiae has been studied extensively and involves a
number of different post-transcriptional regulatory mech-
anisms. Export of ScChs3 from the ER is controlled by the
chaperone ScChs7 and transportation from the Golgi to
the plasma membrane (PM) occurs in specialised vesicles
called chitosomes [31,32]. Generation of the PtdIns(4)P
lipid by ScPik1 promotes forward transport of ScChs3 to
the PM and subsequent de-phosphorylation by ScSac1
terminates the signal, allowing ScChs3 to remain in the
PM and synthesise chitin [33]. ScChs3 is targeted to theCurrent Opinion in Microbiology 2010, 13:416–423
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Figure 3
Phosphorylation of Candida albicans Chs3 on a specific serine residue is required to target the CHS to sites of polarised growth. CaChs3 was tagged
with yellow-fluorescent protein (YFP) and the localisation of the CHS in growing hyphae was observed by time-lapse fluorescence microscopy. (a)
CaChs3-YFP localises to the tip of the growing hypha and then flashes at the site of septum formation. (b)Mislocalisation of CaChs3 is observed when
the serine at position 139 has been mutated to an alanine that cannot be phosphorylated (Chs3S139A-YFP).Modified from [30].bud neck for septum formation at an appropriate time in
the cell cycle through interactions with ScChs4, ScBni4,
ScGlc7 and the septins [14,34–38].
In addition to mechanisms involving post-translational
modifications or protein–protein interactions, some CHSs
are hybrid proteins with N-terminal myosin motor-like
domains (MMD) and C-terminal CHS domains. These
enzymes tend to fall into classes V and VII, and the best
characterised examples from human pathogens include
WdChs5 (the class V enzyme from Wangiella dermatitidis;
[39]), AnCsmA and AnCsmB (class V and VII from A.
nidulans; [40,41]). Using their MMD, these enzymes
appear to localise themselves to sites of polarised cell
wall expansion in an actin-dependent manner [40,42–44].
The MMD may not possess the motor activity of
traditional myosins [43], however, in the plant pathogen
Ustilago maydis, the myosin-like domain of the class V
UmMcs1 enzyme has been shown to be essential for its
apical localisation and is involved in retention of UmMcs1
in the apical dome (G Steinberg, personal communi-
cation).
Chitin and immune recognition
The immune system has evolved to detect conserved,
basic molecular components of microorganisms called
pathogen associated molecular patterns (PAMPs).
b(1,3)-Glucan is a well studied PAMP that is detected
by Dectin-1, a C-type lectin receptor of monocytes and
macrophages, and is of major importance in activating a
strong, pro-inflammatory response by the innate immuneCurrent Opinion in Microbiology 2010, 13:416–423system [45]. In C. albicans, access to the inner cell wall
layer containing b-glucan and chitin is normally shielded
by the superficial mannans and so immune detection of
intact cells is initially focused on mannan-immune re-
ceptor interactions [46]. However, b-glucan can be
unmasked by exposure to host enzymes, antifungal drugs,
heat-treatment and in mannosylation deficient mutants
[47]. In a similar way, an outer a(1,3)-glucan layer masks
detection of the inner chitin/b-glucan layer inHistoplasma
capsulatum [48]. In the case of b-glucan, unmasking has
major immunomodulatory consequences. What therefore
is the immunological role of chitin, the other highly
conserved signature molecule in the inner cell wall?
Recent studies have begun to reveal a complex picture
regarding the immunological properties of chitin [49].
Immune responses seem to be highly dependent on
the size of the chitin fragments used to stimulate immune
cells [50]. Very large (>100 mm) chitin fragments, nor-
mally prepared from invertebrate sources, seem to be
immunologically inert, while intermediate (40–70 mm)
and small chitin (<40 mm) seem capable of activating
macrophages and eliciting IL-17, TNF and IL-23 pro-
duction via a range of pattern recognition receptors
(PRRs) [51]. All of these particles are quite large relative
to the sizes of fungal cells and the molecular scale of
immune receptor–ligand interactions. Also, such exper-
iments have yet to accommodate the fact that the struc-
ture of chitin microfibrils varies significantly in different
organisms and even in different parts of the cell wall [24]
(Figure 1). Size-dependent immune reactivity helpswww.sciencedirect.com
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as acidic mammalian chitinase [52] and chitotriosidase
[53,54] in allergic immune responses. These enzymes
presumably digest chitin into smaller particles, capable
of mediating allergic responses. Their ability to digest
large chitin fragments results in the accumulation of IL-4
expressing basophils, eosinophils and neutrophils in tis-
sues and induces alternative macrophage activation that is
associated with the immunity to certain chitin-containing
parasites such as the helminth Nippostrongylus brasiliensis
[55]. Reciprocally, it appears as though certain human
proteins sequester chitin to dampen immune responses
[56].
Recently, several candidate mediators of chitin mediated
immune responses have been identified. RegIIIg (HIP/
PAP) is a C-type lectin with an affinity for chitin that is
expressed in the neutrophil-like Paneth cells of the small
intestine and is induced by certain bacterial peptidogly-
cans [57]. Peptidoglycans are chemically related to chitin
in so far as they are N-acetylglucosamine containing
polysaccharides and the two molecules can activate some
common cellular responses [58]. FIBCD1 has also been
identified as a calcium-dependent acetyl group-binding
tetrameric chitin-binding receptor [59]. The binding
between this chitin receptor and acetylated BSA could be
inhibited by a variety of acetylated compounds, but not
glucosamine or glucose [59]. The requirement for acety-
lation suggests that this receptor is unresponsive to chit-
osan, which is known to be able to activate dendritic cells
via a TLR4-dependent mechanism [60]. This is import-
ant because fungal pathogens such as the zygomycetous
fungi and C. neoformans have substantial amounts of
deacetylated chitin in their walls. Therefore further chitin
and chitosan immune receptors remain to be identified
and the role of fungal chitin in immune recognition
requires investigation.
Chitin as a target for anti-fungal
chemotherapy
Chitin and chitosan are hallmark polysaccharides that are
present in all known fungal pathogens and not in humans.
Inhibition of chitin synthesis has therefore been proposed
as an attractive target for antifungal therapies.However, no
CHS inhibitor has ever progressed into clinical practice
[61]. Existing CHS inhibitors such as the nikkomycins and
polyoxins are most potent and specific against class I
enzymes but are less effective inhibitors of other classes
of CHS enzymes, and of fungal growth in vivo [61,62].
The discovery of the essential role of C. albicans CHS1
[10] prompted the screening for class II CHS inhibitors.
Roche developed one compound, RO-09-3143, a specific
inhibitor of CaChs1 that was fungistatic to C. albicans, but
cidal in a chs2Dmutant background [63]. This highlighted
the possibility of compensatory functions for different
CHS enzymes and was reinforced by the observation thatwww.sciencedirect.comC. albicans yeast cells stimulated to synthesise chitin by
treatment with Ca2+ and Calcofluor White were able to
grow and divide by forming a novel salvage septum in the
absence the otherwise essential CaCHS1 gene [22].
A common response to cell wall damage is strengthening
of the wall by the production of excess chitin, primarily by
the class IV enzymes such as ScChs3 and CaChs3 [20,64].
This compensatory mechanism is triggered when fungi
are treated with echinocandin drugs [22,65,66].
Enhanced chitin levels reduces susceptibility to echino-
candin drugs in C. albicans [17,22], but reciprocally,
combinations of CHS and glucan synthase inhibitors
are more potent against C. albicans and A. fumigatus than
individual drug treatments [22,67]. These studies high-
light the potential of combination therapies that target
the synthesis of the two major structural polysaccharides
found inmost fungi, in achieving fungicidal regimens that
would prevent the emergence of resistance mechanisms.
In addition, cell wall synthase inhibitors, applied in
combination with antagonists of the signalling pathways
that regulate synthase expression and activity, may have
potential as potent antifungal combination therapies. For
example, the calcineurin pathway is important for regu-
lation of chitin synthesis in C. albicans and A. fumigatus as
well as the response to echinocandin drugs, and drugs that
block the calcineurin pathway act synergistically with the
echinocandins [20,22,67,68].
Conclusions
The primary structure of chitin comprises a single sugar
type and a single inter-sugar linkage. None-the-less it is
diverse in structure and form and is assembled by differ-
ent classes of enzymes encoded by families of genes
whose expression is regulated in a cell cycle-dependent
manner at the transcriptional and post-transcriptional
levels. Recent advances in our understanding of how
chitin synthesis is regulated and responds to cell wall
stress sustains the attraction of this process as a potential
antifungal drug target, possibly in combination with
inhibitors of b(1,3)-glucan synthesis and/or the cell wall
compensatory pathway. The relevance of fungal chitin
synthesis in human disease is also evident in emerging
research defining the role of this fungal signature mol-
ecule in immune recognition mechanisms.
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